Hemlibra; HimExpensive!
Big Pharma's Perspective in a Nut$hell Hemophilia, a truly rotten disease to have... ... But wowee-zowee; Money Honey! Etc. Hemlibra, a new and effective medication for the bleeding disease, is celebrated in the Big Pharma newsletters not for making life possible for the affected, but for the profits... the MARKET . fda , new products , regulatory All revved up and ready to roll, Roche is handed the keys to a multibillion-dollar hemophilia market by john carroll — on October 5, 2018 05:49 AM EDT COST TO THE PATIENT? Over $450,000 a year . Insurance still iffy. Medicare and Medicaid? Fuggidaboudit for now. art credit